Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression

被引:41
作者
Stanzione, R
Picascia, A
Chieffi, P
Imbimbo, C
Palmieri, A
Mirone, V
Staibano, S
Franco, R
De Rosa, G
Schlessinger, J
Tramontano, D
机构
[1] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare Luigi C, I-80131 Naples, Italy
[2] Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy
[3] Univ Naples Federico II, Urol Clin, I-80131 Naples, Italy
[4] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Sez Patol, I-80131 Naples, Italy
[5] Univ Sannio, Fac Sci, Benevento, Italy
[6] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin Gaetano Salv, Catanzaro, Italy
[7] NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA
关键词
D O I
10.1038/labinvest.3780211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Proline-rich kinase 2 (Pyk2), also known as CAK beta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to focal adhesion kinase. Pyk2 is expressed in different cell types including brain cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapidly tyrosine phosphorylated in response to diverse extracellular signals acting via different post receptor pathways. We have investigated whether this protein kinase is functionally expressed in normal and neoplastic prostate tissues. In this study, we demonstrate that Pyk2 is expressed only in normal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignancy of prostate cancer.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 64 条
[1]  
[Anonymous], UROLOGIC PATHOLOGY
[2]  
Balbay MD, 1999, CLIN CANCER RES, V5, P783
[3]  
Berthon P, 1997, INT J CANCER, V73, P910
[4]  
Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995
[5]   Genes upregulated during castration-induced rat prostatic apoptosis: cloning and characterization of new cDNAs [J].
Bruyninx, M ;
Ammar, H ;
Reiter, E ;
Cornet, A ;
Closset, J .
BJU INTERNATIONAL, 2000, 85 (09) :1134-1142
[6]   RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells [J].
Chauhan, D ;
Hideshima, T ;
Pandey, P ;
Treon, S ;
Teoh, G ;
Raje, N ;
Rosen, S ;
Krett, N ;
Husson, H ;
Avraham, S ;
Kharbanda, S ;
Anderson, KC .
ONCOGENE, 1999, 18 (48) :6733-6740
[7]   A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase [J].
Craft, N ;
Shostak, Y ;
Carey, M ;
Sawyers, CL .
NATURE MEDICINE, 1999, 5 (03) :280-285
[8]  
CULIG Z, 1995, WORLD J UROL, V13, P285
[9]  
Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO
[10]  
2-C